about
The diagnosis and management of the Spitz nevus in the pediatric population: a systematic review and meta-analysis protocolThe Effectiveness of Written Action Plans in Atopic Dermatitis.The challenge of scleroderma ulcers.Efficacy and Adverse Events of Oral Isotretinoin for Acne: A Systematic Review.Management of Pain Associated with Selected Conditions in Dermatology.Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept.Postnatal changes in the Rexed lamination and markers of nociceptive afferents in the superficial dorsal horn of the rat.Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions.Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.Prescribing success: Developing an integrated prescription and eczema action plan for atopic dermatitis.Usability, Satisfaction, and Usefulness of an Illustrated Eczema Action PlanPhotoprotection in the Immunosuppressed Pediatric PopulationCystic bone lesions in a boy with Darier disease: a magnetic resonance imaging assessmentFixed drug eruption to ingested propolisDermal non-neural granular cell tumor in a 3-year-old childThe Burden of Moderate to Severe Atopic Dermatitis in Canadian Children: A Cross-Sectional SurveyTreatment of Mycoplasma pneumoniae-Induced Rash and Mucositis With Cyclosporine [Formula: see text]A novel RASA1 mutation causing capillary malformation-arteriovenous malformation (CM-AVM): the first genetic clinical report in East AsiaClinical Insights About Topical Treatment of Mild-to-Moderate Pediatric and Adult Atopic DermatitisContemporary Role of Topical Calcineurin Inhibitors: A Pediatric Dermatology Perspective
P50
Q33560882-A1D0D1C6-7647-4E0D-9593-971EEBFEC549Q35896322-B4341474-B0CA-4F0B-B8DE-FC18A74788F4Q37500626-027BEAB7-1BD5-4D5F-B314-753390120C32Q38764696-C8B9759C-E07D-4214-95D2-9FA29E11DE46Q38852222-554C69AF-111A-469D-80C3-F861D0B71B51Q39786635-88A28F29-D411-494B-96C5-56B80C364C6FQ46889245-E581440B-83A1-4A54-9C62-5FC402BC247EQ48065527-38C41ABD-2201-4F40-AA24-CC0B14DD3904Q50109648-B00CD6CF-F8BB-48F3-B251-C71F57C46114Q53762273-4661359C-8DFE-4381-A0CA-08A063726F1FQ56530092-D023F504-C23E-48D1-9C81-D027B5DE9955Q57455772-4BBE0BAF-7AE6-480E-B8A2-F03C3C7F94F7Q83902380-4CEFD6C7-943D-4CB8-994E-960F20B830A1Q84612699-109297BA-89DF-4CBE-BAAC-BD1ED0FB8879Q88688499-755787A4-C825-4C2F-A8BD-F4B2E1CCAE24Q89175089-7C6ECE82-0DF8-483B-A7A2-A180B2811C1DQ90015752-18EA37A5-D8BB-49A5-B5BA-60FDA2898465Q90351786-DA9CA147-90C9-4FA9-8213-2D0B5EB50E36Q92970544-229342A2-E26D-4634-9939-621623007FADQ93059314-B4E9DD3F-5CF9-42CF-B190-5B47448F9884
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michele Ramien
@ast
Michele Ramien
@en
Michele Ramien
@es
Michele Ramien
@nl
type
label
Michele Ramien
@ast
Michele Ramien
@en
Michele Ramien
@es
Michele Ramien
@nl
prefLabel
Michele Ramien
@ast
Michele Ramien
@en
Michele Ramien
@es
Michele Ramien
@nl
P106
P31
P496
0000-0001-9191-3611